Repligen (RGEN) Misses Q2 EPS by 2c

Repligen (NASDAQ: RGEN) reported Q2 EPS of $0.16, $0.02 worse than the analyst estimate of $0.18. Revenue for the quarter came in at $47.7 million versus the consensus estimate of $46.08 million.

GUIDANCE:

Repligen sees FY2018 EPS of $0.69-$0.73, versus the consensus of $0.71. Repligen sees FY2018 revenue of $185-190 million, versus the consensus of $185.35 million.

For earnings history and earnings-related data on Repligen (RGEN) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• BMO Capital Reiterates Market Perform Rating on Axalta Coating Systems (AXTA)
• Westinghouse said to seek over $50 billion valuation in planned IPO